Meta Ads Case Study: 4-Branch Mumbai Hospital Group — 6 Specialties, Spend Scaled ₹15L to ₹28L, Blended CPL ₹1,050 (2026)

This is an anonymised case study of a Mumbai multi-branch hospital engagement. Real numbers, real six-month timeline, no client name. Hospital advertising in India sits under NMC ethics, ASCI, and — once you wire HIS-linked attribution — the DPDP Act 2023 on the data side. Every decision below had to survive all three.

The client is a multi-location hospital group in Mumbai. Four branches — Powai, Andheri, Thane, Navi Mumbai. 320 beds aggregate. Six clinical specialties running on Meta: cardiac, orthopaedic, gynae/obs, general OPD, health check packages, elective surgery. Monthly Meta spend was ₹15L when we started. Six months later it sits at ₹28L, blended CPL is ₹1,050 (down from ₹1,890), and cardiac admissions traceable to Meta are up 38%. This is the sequence, month by month, including the two things that failed hard enough to kill on the spot.

Day 0 — one CPL number hiding six businesses

The account we inherited had one CPL number reported to the CEO: ₹1,890 blended. That number was doing a lot of harm because it was hiding wild specialty variance. Cardiac was actually at ₹3,860. OPD was at ₹520. Ortho sat around ₹1,400. Gynae was fine at ₹720. Health checks were leaking at ₹1,180. Elective surgery was uneven — some months ₹2,600, some months ₹5,400.

The blended number also hid a bigger problem — 40% of the monthly budget was going into a brand campaign with no CPL, no CPQL, no measurable output. The rationale was "brand builds trust." That may or may not be true. What was definitely true: nobody had ever measured it.

Per-branch attribution was a fiction. The pixel history was fragmented across three ad accounts left over from earlier agency handovers. The offline conversion loop between the hospital's HIS (Hospital Information System) and Meta was not wired at all — meaning treatment-plan-signed and admission events were invisible to the algorithm.

The baseline we wrote:

• Blended CPL: ₹1,890 (hiding six very different specialty economics).
• Per-specialty CPQL: unknown until we calculated it.
• Per-branch attribution: zero.
• Brand budget: 40% of ₹15L = ₹6L/month with no accountability.
• Ad accounts: three, with fragmented pixel history.

Day 14 — three findings that changed the engagement

The Meta Catalyst IQ diagnostic surfaced three findings that reset the conversation.

₹3.8L/month bleeding. The Money Wastage column added it up. Mis-attributed spend across the three ad accounts, three zombie campaigns still live from 2025 (targeting audiences the hospital no longer served), and duplicate audience overlap between branches. All fixable inside two weeks.

Cardiac wasn't broken — the framing was. Cardiac CPL of ₹3,860 looked terrible on the surface. When we calculated CPQL — cost per qualified lead, defined as consult booked and phone-verified — and then walked the funnel further to admission, the picture flipped. Cardiac had a 4.2% consult-to-admission rate. On the average cardiac admission economics of the hospital, the CPQL of ₹6,800 was actually delivering a healthy ROAS. The blended number and the "high" cardiac CPL had been scaring the CFO out of spending more on the specialty that was earning most.

PrismSpy competitor watch flagged four hospital groups the client wasn't benchmarking. Two Andheri-adjacent chains were running cardiac and gynae creative continuously. One Powai player was running a health-check-package hook the client should have been running two years ago. One Thane group had cornered the ortho local search intent with a specific creative angle nobody else was using.

Week 4 — six specialty pods inside one portfolio

The restructure took three weeks of build and one week of migration. New shape:

• One consolidated portfolio ad account.
• Six specialty pods (cardiac, ortho, gynae/obs, general OPD, health check, elective surgery), each with its own campaign structure, LP set, creative library, and CPQL target.
• Four per-branch geo-fences layered on top for local relevance.
• Brand budget cut from 40% to 22% with one specific KPI — measurable brand lift + assisted-conversion contribution, not "vibes."

The biggest technical build was the HIS-Meta offline conversion loop. The hospital's HIS captured admission and treatment-plan-signed events. We wrote a nightly pipeline that hashed patient phone numbers, matched them against Meta's CAPI ingestion, and fed downstream conversion events back to Meta's ML with a 7-day lookback. This is a DPDP Act 2023 exercise as much as a marketing one — hashing, consent, data-controller responsibility, retention limits. The DPDP framework shaped the whole pipeline, and the hospital's DPO reviewed it before we shipped.

Channel-fit rules per specialty:

• OPD and health-check packages — WhatsApp-first (low friction, high volume, price-sensitive).
• Elective surgery — form-first (patient wants to research before talking to anyone).
• Cardiac emergency-adjacent — call-first (time-critical intent, phone conversion is the right unit).
• Ortho, gynae — hybrid form + WhatsApp with per-branch routing.

Week 8 — first real numbers

By week 8:

• Blended CPL: ₹1,120 (down from ₹1,890, a 41% drop).
• Per-specialty CPQL improvements: cardiac -32%, ortho -38%, gynae -26%, OPD -42%, health check -48%, elective surgery -34%.
• Cardiac admissions from Meta: traceable for the first time.

The cardiac admission traceability was the moment the CEO changed how he talked about Meta internally. Before this, Meta was a marketing line item. After this, it was a patient-acquisition channel with a measurable admission unit economics. That shift matters more than any dashboard.

Week 12 — scaling to ₹22L

We had permission to scale by week 10. Month 3 ended at ₹22L/month. Blended CPL ₹1,050. Cardiac admissions traceable to Meta up 38% over month 1. Ortho consults up 51%. OPD volume up 62% — OPD scales fastest because the funnel is shortest and the conversion event is a same-week walk-in.

Two things kept the CPL from drifting up as spend scaled. First, the pod structure meant each specialty had its own creative refresh cadence — we didn't let one specialty's fatigue drag the whole account. Second, per-branch geo-fencing meant we could scale spend in Thane and Powai without cannibalising Andheri.

Month 6 — the lock-in at ₹28L

By month 6 the account was at ₹28L/month sustained. All six specialties clean. Brand campaigns measurable via brand-lift studies and assisted-conversion attribution — not perfect, but measurable, which is the bar the CEO had asked for.

Per-branch performance visible to the CEO in a single Master Dashboard view. Powai and Andheri were carrying gynae. Thane was carrying ortho. Navi Mumbai had a genuinely competitive advantage on cardiac timing. That kind of visibility is what a multi-location group has to have to plan capex, expand specialties, and reallocate marketing budget rationally.

Meta Catalyst IQ Master Dashboard — cross-client portfolio rollup: 23 clients, ₹9.14Cr spend, 5,784 leads, blended CPL ₹1,581, CAC ₹86,253" loading="lazy" decoding="async" style="width:100%;height:auto;display:block;">

Final Month 6 numbers:

• Spend: ₹28L/month.
• Blended CPL: ₹1,050 (44% reduction from baseline).
• Cardiac admissions traceable to Meta: +38% vs Month 1.
• Ortho consults: +51%.
• OPD volume: +62%.
• Health-check package sales: +72%.

What didn't work — two failures worth naming

Cardiac lead-magnet quiz. We built a "heart-health risk quiz" as a top-of-funnel lead magnet for cardiac. CPL for quiz starts was ₹180 — cheap. Quiz completion was 22%. Consult-to-book from completed quizzes was 3%. Blended CPQL from quiz traffic was ₹8,900 — worse than the baseline cardiac CPQL. We killed the quiz at day 30. Our best guess: cardiac patient intent doesn't enter through a quiz. Patients either have a symptom or a family history and want to talk to a cardiologist. The gamified funnel added friction they didn't want.

Language rotation on cardiac creative in Andheri. We shipped Hindi and Marathi voiceovers on cardiac creative for the Thane and Navi Mumbai branches — worked well, CPL down 22% on the Marathi variant. Rolled the same rotation into Andheri assuming urban-Mumbai patients would respond similarly. It backfired. Andheri's patient set for cardiac skewed English-preferred and the Hindi/Marathi variants underperformed the English original by 34%. Language fit is hyper-local. We now test language rotations branch-by-branch before rolling.

Compliance — NMC ethics, ASCI, DPDP on the HIS side

Hospital advertising in India runs under three overlapping compliance regimes.

NMC ethics on hospital advertising restricts guarantee-of-cure claims, disallows testimonials that promise specific outcomes, and requires that any specialist named in ads carries a valid state council registration. Every doctor-led creative on this account went through a compliance check against the current NMC ethics code before ship.

ASCI 2022 layers on the general advertising standards — no misleading before-and-after, no unsubstantiated claims, no denigration of competitors. The Maharashtra Medical Council adds a state layer on top.

DPDP Act 2023 was the biggest change to how we build hospital-Meta pipelines. Once you wire an HIS-linked offline conversion loop, you are processing personal health data at scale. Hashing, consent, purpose limitation, and retention rules all apply. The hospital's DPO signed off on the pipeline before we ingested a single event.

What to replicate if you run a multi-specialty hospital group

Five things transfer to any multi-specialty hospital account.

One — never report a blended CPL to the CEO. It hides too much. Report per-specialty CPQL with the admission economics attached. A ₹3,800 cardiac CPL that closes 4% of admissions is a different business from a ₹380 OPD CPL that closes 1.5% into paid procedures.

Two — wire the HIS offline conversion loop before you scale spend. Meta's algorithm gets 3-5x better at optimisation once it sees admission and treatment-plan-signed events, not just consult-booked.

Three — cut brand budget until it has a measurable KPI. 40% of spend with no accountability is not a brand strategy. It's a leak. On this account we clawed back ₹6L/month for specialty spend and the brand budget is now measurable.

Four — separate channel-fit by specialty. Cardiac doesn't belong on the same lead-capture pattern as OPD. Elective surgery patients want a research phase. Emergency-adjacent patients want a phone number.

Five — test language and creative rotations per branch, not per city. Andheri and Thane are 22 km apart and the audiences behave differently. We had to learn this the hard way.

Powered by Meta Catalyst IQ — the decision engine behind every Meta ad ICG runs

ICG built Meta Catalyst IQ because most Indian healthcare brands running Meta ads waste 30-50% of budget without knowing it. On this hospital account, Catalyst IQ's Money Wastage column surfaced the ₹3.8L/month leak in the first fortnight. It is the diagnosis and decision layer above Ads Manager — Hygiene Factors 12-point checklist, Naming Intelligence (surfaces conflicts costing ₹50K-₹2L per account per month), Creative Scoring Matrix (Core Performer, Scalable, Getting Started, Review), 2-Day Comparative, SLC Framework, Money Wastage column in ₹.

• Master Dashboard — 23+ accounts, ₹9.1Cr+ spend/month optimised, ₹1,581 blended CPL vs ~₹3,200 market benchmark.
• Diagnose → Optimise → Grow — daily hygiene checks, weekly creative scoring, monthly money wastage cleanup.
• CPQL Engine — cost per qualified lead (not just cost per lead) at ad-set level. Try the interactive CPQL calculator.
• Portfolio benchmarks — IVF ₹632, derm ₹520-1,180, dental ₹620-1,800, aesthetic ₹400-900, hospital cardiac ₹3,200.

Included free with every ICG Meta ads or Performance Marketing engagement (Starter ₹20,000/-/month tier and above). Not sold standalone. Book a free 48-hour Meta ad diagnostic or WhatsApp us.

Powered by PrismSpy — every competitor Meta ad, watched daily

ICG built PrismSpy because Indian healthcare Meta ad competition is invisible without it. On this hospital account, the four benchmarking gaps we closed came directly from the PrismSpy Mumbai hospital watchlist. 75+ Indian healthcare brands tracked, 2,150+ active ads catalogued, ₹50Cr+ aggregate ad spend visibility per month. Every competitor ad — creative, offer, hook, run-length — refreshed daily. It runs underneath every Meta ads and performance marketing engagement at ICG.

• Watchlist Dashboard — 30-75 competitors per specialty cluster (IVF / dermatology / dental / hair transplant / aesthetic / hospital), daily refresh.
• Comparative Insights — highest-quality ads, longest-running creatives (proven converters), top hooks, emerging offers.
• Offers Intelligence — 1,197 offers tracked, discount intensity by brand, value tier distribution.
• Service Cluster + Inspirations — 419 services tracked, 4,697 searchable ad inspirations by hook / language / format.

Standalone from ₹4,999/- per specialty vertical, or bundled free inside HealthApex OS (₹14,999/- flat, 9 tools). Book a 30-min PrismSpy walkthrough on WhatsApp — Rohit + Hanuman walk you through your specialty's competitive landscape.

angryturtle/01-listing-overview.png" alt="Angryturtle Listing Overview — GBP watchlist with per-listing status, category, sub-scores, action count for 143+ managed Indian healthcare listings" loading="lazy" decoding="async" style="width:100%;height:auto;display:block;">

FAQ

Why is a blended hospital CPL misleading?

Because it averages six businesses with different economics. Cardiac admissions and OPD walk-ins are not comparable units. The blended number let the CFO under-invest in cardiac because the CPL looked high — when the CPQL and admission ROAS were actually strong.

What does HIS-linked offline conversion actually give you?

Meta's optimisation algorithm gets to see the events that matter to the hospital — treatment-plan-signed, admission — not just consult-booked. That improves the algorithm's targeting by roughly 3-5x on our accounts.

Is HIS-linked attribution DPDP-compliant?

Yes, but only if you build it right. Phone-hash before transmission, explicit patient consent covering marketing-attribution use, retention limits, and DPO sign-off. We don't ship the pipeline until the hospital's DPO reviews it.

How did brand budget get from 40% to 22%?

We asked the CEO what specific brand KPI the 40% was earning. There wasn't one. We proposed a brand-lift study and assisted-conversion attribution as the measurement layer, and reallocated the freed budget to specialty pods.

Why did the cardiac quiz fail?

Because cardiac patient intent doesn't enter through gamified funnels. Patients either have a symptom or a family history and want a cardiologist. The quiz added friction they didn't want. This is the "wrong funnel for the intent" failure mode.

How local does language testing need to be for Mumbai hospitals?

Branch-by-branch, not city-wide. Andheri's cardiac audience skewed English-preferred. Thane and Navi Mumbai responded well to Hindi and Marathi. We now default to per-branch language tests before any rollout.

Can a two-branch hospital replicate this?

Yes. The portfolio consolidation is smaller — two branches means two geo-fences instead of four. The HIS-linked attribution loop still applies, and the "don't report blended CPL" rule still applies. If anything, small groups benefit more because they can't afford to hide leakage.

Related reading

• How to reduce Meta ads CPL in healthcare India
• NMC Ethics Code 2026 for healthcare advertising
• DPDP Act compliance for healthcare Meta ads
• WhatsApp vs form fill for healthcare lead conversion
• Meta ads vs Google ads for healthcare in India
• ICG Healthcare Meta Ads services
• HealthApex OS — 9 tools bundled

Talk to us if you run a multi-specialty hospital

If your hospital reports a blended CPL and you can't answer "which specialty earns which rupee," we can rebuild that measurement layer in under 30 days. Book a free Meta ad diagnostic or WhatsApp us. Hanuman leads the hospital pod at ICG. He'll look at the account personally before any commercial conversation.